Related Experiment Video
Updated: Jan 13, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
Knowledge graph integration of clustered medicinal plants, molecules, diseases, and targets
U K Shajil1, Jaleel Uca2, S Sathish2
1Department of Bioscience and Engineering, National Institute of Technology Calicut, Kerala 673601, India.
None:
This study builds on the premise that phytochemicals, when co-existing across multiple plant species, tend to form structural and functional clusters. While individual compounds may exhibit distinct pharmacological properties in isolation, their behaviour within molecular clusters often diverges, potentially leading to emergent synergistic effects. Leveraging this insight, we systematically analysed 490 phytoconstituents derived from ten medicinal plants belonging to the Dasamoola group. Through chemoinformatic clustering using K-Means and dimensionality reduction via t-SNE, these molecules were organised into 49 structurally coherent clusters. Pharmacological relevance was assessed by mapping clusters to 87 ICD-11-classified disease conditions, thereby integrating clustering, ICD-11 mapping, and knowledge-graph visualization into a unified workflow that can serve as a template for analysing other complex polyherbal formulations. Heat map analyses revealed significant correlations between molecular clusters and disease phenotypes, indicating potential poly pharmacological mechanisms. To further elucidate these relationships, predicted molecular targets were integrated with disease ontologies using a Neo4j-based knowledge graph framework. This network-based approach enabled the visualization of molecule-target-disease associations, suggesting mechanistic insights that extend beyond conventional reductionist perspectives in an exploratory manner. Overall, our findings suggest potential molecular-target-disease associations that link structurally related phytochemicals to defined disease categories through shared biological targets. These associations indicate plausible network-level relationships and offer new avenues for, understanding the systems-level pharmacology of traditional medicinal formulations, generating testable hypothesis that warrant further experimental validation.
More Related Videos
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drug Discovery: Overview
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Combined Effects of Drugs: Synergism
Such synergistic combinations...